The content on this site is intended for healthcare professionals only
Dr Lievens talks to ecancertv at the 3rd ESTRO forum about the increased costs of healthcare expenses.
She discusses the need to evaluate the way in which we allocate our resources in an optimal way to benefit every cancer patient.
She also discusses how to improve the access to treatments and how to increase quality and guarantee the full potential of the novel treatments being developed.
Cancer mutation prediction using artificial intelligence
Multiple myeloma in a resource constrained setting
Choosing Wisely in pathology
Choosing Wisely in radiology Tanzania
TARGeted IORT INTRABEAM is a useful treatment option for early stage breast cancer
Breast and emerging indications for IORT
Combination of camonsertib plus PARPi shows clinical activity in DDR-aberrant tumours
Why tumour markers are not recommended as screening tests
Moving to the future: Artificial intelligence in surgery
